How to confirm a drug is a highly variable drug? [Design Issues]

posted by wxp  – China, 2013-03-22 02:58 (4849 d 02:26 ago) – Posting: # 10258
Views: 5,064

(edited on 2013-03-22 10:17)

Hi ElMaestro,

I agree with the way you mentioned. But it is time-consuming and needs more money.We did a 2×2 bioequivalance study of simvastin in 24 healthy volunteers. The intra-CV was >30%, which demonstrated that the sample size was not enough for a HV drug. I think if we can confirm a drug a HV drug before the study design, it will save a lot of time and money.

Best regards,


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]

Best regards,

Xipei
China

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
318 visitors (0 registered, 318 guests [including 11 identified bots]).
Forum time: 06:25 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5